Chiron Corporation (Now Novartis Vaccines & Diagnostics)

15 articles about Chiron Corporation (Now Novartis Vaccines & Diagnostics)

• Chiron AS Establishes State-of-the-Art Research Centre in Trondheim, Norway, Advancing Environmental Surveillance

  1/17/2024

  Chiron AS, a leading producer of chemical reference materials headquartered in Trondheim, Norway, is pleased to announce the establishment of a state-of-the-art research centre dedicated to the enhanced surveillance of environmental pollutants.

• 

  Replicate Launches with $40 Million to Eliminate Drug Resistance in Cancer

  9/8/2021

  Replicate focuses on using self-replicating RNA (srRNA) to develop therapies for autoimmune and inflammatory diseases and prevent drug resistance in cancer. 
• 

  Judge Orders Novartis to Cough Up $178 Million to Plexxikon Over Patent Infringements

  7/23/2021

  Novartis claimed the patents held by Plexxikon were invalid. Unfortunately for the company, the jury found it was unable to prove these claims.
• 

  Novartis Takes Roche to Court Over $210 Million Licensing Fees

  6/29/2021

  The deal was originally inked in 2005, where U.S.-based Chiron Corp. made payments to Genentech, a Roche company. 

• New Era For Biotech?

  2/10/2005

• Chiron Scrambles To Reopen British Plant For Flu Season

  1/17/2005

• The Day In Review: Biotech Moves Lower

  12/10/2004

• FDA Saw Problems At Vaccine Plant In 2003

  11/18/2004

• Web Site Tracks Vaccine Supply

  10/28/2004

• U.S. Squeezes Out A Few Million More Flu Vaccines

  10/20/2004

• Desperately Seeking Flu Vaccine? Get In Line; No Chance Of Chiron Vaccine

  10/18/2004

• U.S. Department Of Health & Human Services Release: HHS Secretary Urges States To Aggressively Prosecute Flu Vaccine Price Gouging

  10/15/2004

• Biotech Can't Get A Break

  10/11/2004

• Playing The High-Stakes Biotech Game

  7/8/2004

• What's Driving Biotech

  6/23/2004